| BGF 320/18/9.6 µg (N = 22) | GFF 18/9.6 µg (N = 23) | Total (N = 23) |
---|---|---|---|
Mean age, years (SD) | 64.8 (7.8) | 64.9 (7.6) | 64.9 (7.6) |
Male, n (%) | 17 (77.3) | 18 (78.3) | 18 (78.3) |
Current smoker, n (%) | 10 (45.5) | 10 (43.5) | 10 (43.5) |
 Median pack-years smoked, (range) | 40.5 (15–100) | 41.0 (15–100) | 41.0 (15–100) |
Severity of COPD (GOLD), n (%) | Â | Â | Â |
 Moderate | 17 (77.0) | 17 (73.9) | 17 (73.9) |
 Severea | 5 (22.7) | 6 (26.1) | 6 (26.1) |
COPD exacerbations per patient (past 12Â months), mean (SD) | 0.2 (0.5) | 0.2 (0.5) | 0.2 (0.5) |
Total CAT score (0–40)b, mean (SD) | 17.6 (5.5) | 17.3 (5.6) | 17.3 (5.6) |
FEV1 at Visit 1 (% predicted) | Â | Â | Â |
 Pre-bronchodilator, mean (SD) | 58.9 (13.3) | 58.4 (13.1) | 58.4 (13.1) |
 Post-bronchodilator, mean (SD) | 64.1 (13.7) | 63.6 (13.7) | 63.6 (13.7) |
 FEV1/FRC post-bronchodilator at Visit 1, mean (SD) | 52.0 (10.6) | 51.7 (10.5) | 51.7 (10.5) |
% predicted RV, mean (SD) | 173.7 (44.9) | 173.2 (43.9) | 173.2 (43.9) |
TLC (L), mean (SD) | 7.5 (1.5) | 7.4 (1.4) | 7.4 (1.4) |
% predicted FRC, mean (SD) | 150.4 (26.6) | 149.8 (26.2) | 149.8 (26.2) |